Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000155746 | SCV000169951 | benign | not specified | 2012-03-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000155746 | SCV000205456 | likely benign | not specified | 2018-02-28 | criteria provided, single submitter | clinical testing | c.-5T>C in the 5'UTR of KCNQ1: This variant is classified as likely benign becau se it has been identified in 0.34% (47/13662) of European chromosomes by the Gen ome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs532 941548). ACMG/AMP Criteria applied: BS1. |
Ambry Genetics | RCV000242002 | SCV000319135 | likely benign | Cardiovascular phenotype | 2018-05-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000725213 | SCV000335034 | uncertain significance | not provided | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000389967 | SCV000370195 | likely benign | Long QT syndrome 1 | 2018-08-15 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000310463 | SCV000370196 | uncertain significance | Atrial fibrillation, familial, 3 | 2018-08-15 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV000364999 | SCV000370197 | likely benign | Congenital long QT syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000270523 | SCV000370198 | uncertain significance | Short QT syndrome type 2 | 2018-08-16 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV000307327 | SCV000370199 | uncertain significance | Jervell and Lange-Nielsen syndrome 1 | 2018-08-15 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Athena Diagnostics Inc | RCV000725213 | SCV001144353 | uncertain significance | not provided | 2018-11-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000725213 | SCV001248097 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | KCNQ1: BP4 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000155746 | SCV001339051 | benign | not specified | 2022-01-31 | criteria provided, single submitter | clinical testing | Variant summary: KCNQ1 c.-5T>C is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 0.0027 in 146374 control chromosomes in the gnomAD database (v3.1 genomes dataset), including 1 homozygote. The observed variant frequency is approximately 26-fold higher than the estimated maximal expected allele frequency for a pathogenic variant in KCNQ1 causing Arrhythmia phenotype (0.0001), strongly suggesting that the variant is benign. c.-5T>C has been reported in the literature in individuals affected with or being tested for LQTS, without strong evidence for causality (Jongbloed_2002, Stattin_2012). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six other clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as likely benign (n=4) or VUS (n=2). Based on the evidence outlined above, the variant was classified as benign. |
Clinical Genetics, |
RCV000155746 | SCV001923127 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000725213 | SCV001931844 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000725213 | SCV001957121 | likely benign | not provided | no assertion criteria provided | clinical testing |